<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">79208</article-id><article-id pub-id-type="doi">10.7554/eLife.79208</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Highly efficient generation of isogenic pluripotent stem cell models using prime editing</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-276208"><name><surname>Li</surname><given-names>Hanqin</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7995-1084</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276209"><name><surname>Busquets</surname><given-names>Oriol</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1372-9699</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276210"><name><surname>Verma</surname><given-names>Yogendra</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276211"><name><surname>Syed</surname><given-names>Khaja Mohieddin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276212"><name><surname>Kutnowski</surname><given-names>Nitzan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3012-4616</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276213"><name><surname>Pangilinan</surname><given-names>Gabriella R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45861"><name><surname>Gilbert</surname><given-names>Luke A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-95866"><name><surname>Bateup</surname><given-names>Helen S</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0135-0972</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-4600"><name><surname>Rio</surname><given-names>Donald C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4775-3515</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-198560"><name><surname>Hockemeyer</surname><given-names>Dirk</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5598-5092</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-275487"><name><surname>Soldner</surname><given-names>Frank</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7102-8655</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Molecular and Cell Biology</institution>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Dominick P Purpura Department of Neuroscience</institution>, <institution>Albert Einstein College of Medicine</institution>, <addr-line><named-content content-type="city">Bronx</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Cellular and Molecular Pharmacology, California Institute for Quantitative Biomedical Research</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Molecular and Cellular Biology</institution>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-214741"><name><surname>Méndez-Ferrer</surname><given-names>Simón</given-names></name><role>Reviewing editor</role><aff><institution>University of Cambridge</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>don_rio@berkeley.edu</email> (DR);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>frank.soldner@einsteinmed.edu</email> (FS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>07</day><month>09</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e79208</elocation-id><history><date date-type="received"><day>04</day><month>04</month><year>2022</year></date><date date-type="accepted"><day>06</day><month>09</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Li et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Li et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-79208-v1.pdf"/><abstract><p>The recent development of prime editing (PE) genome engineering technologies has the potential to significantly simplify the generation of human pluripotent stem cell (hPSC)-based disease models. PE is a multi-component editing system that uses a Cas9-nickase fused to a reverse transcriptase (nCas9-RT) and an extended PE guide RNA (pegRNA). Once reverse transcribed, the pegRNA extension functions as a repair template to introduce precise designer mutations at the target site. Here, we systematically compared the editing efficiencies of PE to conventional gene editing methods in hPSCs. This analysis revealed that PE is overall more efficient and precise than homology-directed repair (HDR) of site-specific nuclease-induced double-strand breaks (DSBs). Specifically, PE is more effective in generating heterozygous editing events to create autosomal dominant disease-associated mutations. By stably integrating the nCas9-RT into hPSCs we achieved editing efficiencies equal to those reported for cancer cells, suggesting that the expression of the PE components, rather than cell-intrinsic features, limit PE in hPSCs. To improve the efficiency of PE in hPSCs, we optimized the delivery modalities for the PE components. Delivery of the nCas9-RT as mRNA combined with synthetically generated, chemically-modified pegRNAs and nicking guide RNAs (ngRNAs) improved editing efficiencies up to 13-fold compared to transfecting the prime editing components as plasmids or ribonucleoprotein particles (RNPs). Finally, we demonstrated that this mRNA-based delivery approach can be used repeatedly to yield editing efficiencies exceeding 60% and to correct or introduce familial mutations causing Parkinson's disease in hPSCs.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100018231</institution-id><institution>Aligning Science Across Parkinson's</institution></institution-wrap></funding-source><award-id>ASAP-000486</award-id><principal-award-recipient><name><surname>Gilbert</surname><given-names>Luke A</given-names></name><name><surname>Bateup</surname><given-names>Helen S</given-names></name><name><surname>Rio</surname><given-names>Donald C</given-names></name><name><surname>Hockemeyer</surname><given-names>Dirk</given-names></name><name><surname>Soldner</surname><given-names>Frank</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007319</institution-id><institution>Albert Einstein College of Medicine, Yeshiva University</institution></institution-wrap></funding-source><award-id>Internal research support from the Department of Neuroscience</award-id><principal-award-recipient><name><surname>Soldner</surname><given-names>Frank</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100015596</institution-id><institution>Siebel Stem Cell Institute</institution></institution-wrap></funding-source><award-id>Fellow</award-id><principal-award-recipient><name><surname>Bateup</surname><given-names>Helen S</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Sequencing data can be accessed through the repository platform Zenodo (10.5281/zenodo.6941502). The datasets for AAVS1 knock-in genotyping, aCGH karyotyping, and the source data files used to generate the featured graphs and tables can be found on Zenodo (10.5281/zenodo.6941599). Plasmids referred to in this paper have been deposited to Addgene's Michael J. Fox Foundation Plasmid Resource and their associated RRID can be found in Supplemental table 2.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Li H</collab><collab>Busquets O</collab><collab>Verma Y</collab><collab>Syed K</collab><collab>Kutnowski N</collab><collab>Pangilinan G</collab><collab>Gilbert L</collab><collab>Bateup H</collab><collab>Rio D</collab><collab>Hockemeyer D</collab><collab>Soldner F</collab></person-group><year iso-8601-date="2022">2022</year><source>Bulk NGS/allele quantification - Highly efficient generation of isogenic pluripotent stem cell models using prime editing</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.6941502">https://doi.org/10.5281/zenodo.6941502</ext-link><comment>Zenodo, doi:10.5281/zenodo.6941502</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Li H</collab><collab>Busquets O</collab><collab>Verma Y</collab><collab>Syed K</collab><collab>Kutnowski N</collab><collab>Pangilinan G</collab><collab>Gilbert L</collab><collab>Bateup H</collab><collab>Rio D</collab><collab>Hockemeyer D</collab><collab>Soldner F</collab></person-group><year iso-8601-date="2022">2022</year><source>Highly efficient generation of isogenic pluripotent stem cell models using prime editing - Datasets</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.6941599">https://doi.org/10.5281/zenodo.6941599</ext-link><comment>Zenodo, doi:10.5281/zenodo.6941599</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-79208-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>